ACON — Aclarion, Inc.
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Company profile
- Sector: Healthcare
- Industry: Medical - Healthcare Information Services
- Country: US
- Exchange: NASDAQ Capital Market
- Employees: 5
- Website: https://www.aclarion.com
Latest SEC filings for ACON
- 10-Q — 2026-05-13
- 8-K — 2026-04-22
- 8-K — 2026-01-13
- 8-K — 2026-01-09
- 424B5 — 2026-01-09
- 10-Q — 2025-11-12
- 8-K — 2025-10-14
- 424B5 — 2025-10-14
- 8-K — 2025-09-03
- 10-Q — 2025-08-14
Latest ACON news
- — Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026 (GlobeNewswire Inc.)
- — Aclarion to Present at the 20th Annual LD Micro Main Event (globenewswire.com)
- — Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment (GlobeNewswire Inc.)
- — Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites (globenewswire.com)
Educational tool only — not investment advice.